EN DE
STOCK COMPARISON

Apollo Hospitals Enterprise vs HCA Healthcare: Fair Value & Quality

Both stocks run through our valuation models. Here is how Apollo Hospitals Enterprise (APOLLOHOSP) and HCA Healthcare (HCA) compare, as of Aug 3, 2026.

As of Aug 3, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Apollo Hospitals Enterprise trades at ₹8,957 versus a fair value of ₹2,908 (-68%), while HCA Healthcare trades at $403 versus $555 (+38%).
Apollo Hospitals Enterprise
APOLLOHOSP.NSE · INR · Health Care
-68%
upside to fair value
overvalued
Price₹8,957
Fair Value₹2,908
Quality66/100
HCA Healthcare
HCA · USD · Health Care
+38%
upside to fair value
undervalued
Price$403
Fair Value$555
Quality62/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Apollo Hospitals EnterpriseHCA Healthcare
Valuation
65.4×P/E (TTM)12.5×
5.04×P/S (TTM)1.06×
13.41×P/B
34.1×EV/EBITDA7.8×
PEG1.18×
0.2%Dividend yield0.8%
₹20.00Dividend per share$2.94
Profitability
8%Net margin9%
12%Operating margin15%
22%Return on equity136%
8%Return on assets12%
Growth
18%Revenue growth (YoY)4%
14.9%Avg. growth/yr (3Y)7.9%
19.0%Avg. growth/yr (5Y)8.0%
Balance & size
0.26×Debt / equity
$13BMarket cap$81B
mixedGrowth qualityhealthy

HCA Healthcare leads: 3 to 8 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Apollo Hospitals Enterpriseof which business quality 57 · market factors 78 HCA Healthcareof which business quality 66 · market factors 44
ProfitabilityMargins and returns on capital today
65
76
Quality GrowthAre margins and returns improving?
70
61
CashflowEarnings quality: real cash, not paper profit
32
62
Fin. StrengthBalance sheet, leverage, solvency risk
58
39
InvestmentDisciplined investing over empire-building
38
75
Low VolatilityCalm price path (market factor)
96
59
MomentumPrice trend over the last 3–12 months (market factor)
66
35
52W MomentumDistance to the 52-week high (market factor)
78
43
Net IssuanceBuybacks instead of dilution
82
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Apollo Hospitals Enterprise

DCF Models₹3,028
Earnings-Based₹2,247
Dividend Discount₹382
Multiples₹2,613
Asset-Based₹442
Growth DCF₹2,292
Economic Profit₹2,013
Growth Earnings₹3,193

26 of 26 models see the stock below the current price.

HCA Healthcare

DCF Models$519
Earnings-Based$289
Dividend Discount$53.85
Multiples$612
Growth DCF$540
Economic Profit$419
Growth Earnings$478

6 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Apollo Hospitals Enterprise
Bear ₹1,573Fair Value ₹2,908Bull ₹4,338
₹8,957 = current price (white tick)
HCA Healthcare
Bear $270Fair Value $555Bull $841
$403 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Apollo Hospitals Enterprise · Health Care

Quality score66 · Top 25%
Fair value upside-68% · below median

HCA Healthcare · Health Care

Quality score62 · Top 25%
Fair value upside+38% · Top 25%

Bottom line

As of Aug 3, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Apollo Hospitals Enterprise trades at ₹8,957 versus a fair value of ₹2,908 (-68%), while HCA Healthcare trades at $403 versus $555 (+38%).

Apollo Hospitals Enterprise has the higher quality score (66/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.